Research news
Study supports new screening method for cervical cancer
A pilot study of screening for high risk human papillomavirus in England finds it has greater sensitivity than liquid-based cytology testing
A pilot study of screening for high risk human papillomavirus in England finds it has greater sensitivity than liquid-based cytology testing
A national roll-out of screening for routine primary high risk human papillomavirus (hrHPV) is under way in England. To support it, a large pilot study of routine testing for hrHPV examined the prevalence and incidence of cervical intraepithelial neoplasia (CIN, the pre-cancerous abnormalities) and cancer, comparing it with liquid-based cytology (LBC).
Testing was conducted in 2013-14, with follow-up in 2017.
Women testing hrHPV positive and cytology positive were referred for colposcopy, while those hrHPV positive but cytology negative were recalled early (at
...Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Primary Health Care
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
Already registered or subscribed? Log in
This article is not available as part of an institutional subscription. Why is this?
